Autumn Glory Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,967
Closed -$709K 210
2025
Q4
$709K Buy
8,967
+205
+2% +$16.1K 0.25% 100
2025
Q3
$700K Buy
8,762
+33
+0.4% +$2.81K 0.29% 93
2025
Q2
$793K Sell
8,729
-176
-2% -$16.1K 0.37% 74
2025
Q1
$851K Buy
8,905
+3,586
+67% +$321K 0.42% 69
2024
Q4
$484K Hold
5,319
0.24% 100
2024
Q3
$552K Hold
5,319
0.21% 122
2024
Q2
$516K Sell
5,319
-17,156
-76% -$1.58M 0.26% 91
2024
Q1
$2.02M Buy
22,475
+17,156
+323% +$1.45M 0.99% 31
2023
Q4
$424K Buy
5,319
+140
+3% +$10.5K 0.24% 95
2023
Q3
$368K Buy
5,179
+25
+0.5% +$1.87K 0.22% 98
2023
Q2
$397K Buy
+5,154
New +$399K 0.29% 84

Other funds holding CL

Autumn Glory Partners's CL Position: Q1 2026 in Review

Autumn Glory Partners sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 8,967 shares — an estimated $709K sold.

Autumn Glory Partners first reported a position in CL in Q2 2023 and held it in 11 quarters. The position peaked at $2.02M in Q1 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Autumn Glory Partners reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Autumn Glory Partners sold 8,967 Colgate-Palmolive shares in Q1 2026, an estimated $709K.
  • Autumn Glory Partners first reported a position in Colgate-Palmolive in Q2 2023 and held it in 11 quarters.
  • Autumn Glory Partners's Colgate-Palmolive position peaked at $2.02M in Q1 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Autumn Glory Partners's 13F filing for Q1 2026, filed 4 May 2026.